1. Academic Validation
  2. Inactivation of menin, a Smad3-interacting protein, blocks transforming growth factor type beta signaling

Inactivation of menin, a Smad3-interacting protein, blocks transforming growth factor type beta signaling

  • Proc Natl Acad Sci U S A. 2001 Mar 27;98(7):3837-42. doi: 10.1073/pnas.061358098.
H Kaji 1 L Canaff J J Lebrun D Goltzman G N Hendy
Affiliations

Affiliation

  • 1 Calcium Research Laboratory, Royal Victoria Hospital, McGill University, Montreal, QC, Canada H3A 1A1.
Abstract

Multiple endocrine neoplasia type 1 (MEN1) is an autosomal dominant disorder characterized by endocrine tumors of parathyroids, pancreatic islets, and anterior pituitary. The MEN1 gene encodes a nuclear protein called menin. In MEN1 carriers inactivating mutations give rise to a truncated product consistent with menin acting as a tumor suppressor gene. However, the role of menin in tumorigenesis and its physiological functions are not known. Here, we show that menin inactivation by antisense RNA antagonizes transforming growth factor type beta-mediated cell growth inhibition. Menin interacts with SMAD3, and antisense menin suppresses transforming growth factor type beta-induced and Smad3-induced transcriptional activity by inhibiting SMAD3/4-DNA binding at specific transcriptional regulatory sites. These results implicate a mechanism of tumorigenesis by menin inactivation.

Figures